Factors associated with the acceptability of self-injection training by clients receiving DMPA-SC services from community pharmacies and Patent and Proprietary medicine Vendors in Nigeria
Document Type
Data Set
Publication Date
9-6-2024
Abstract
The self-administration of the subcutaneous depot medroxyprogesterone acetate (DMPA-SC) has the potential to empower women and improve contraceptive use. Several studies have demonstrated the acceptability of the provider-administered DMPA-SC, for private, public, or community-based health providers, but less is known about self-injection training from community pharmacists (CPs) and Patent and Proprietary medicine Vendors (PPMVs) (also known as drug shops).
The dataset includes 186 new and returning users of the DMPA-SC who reported self-injection after being trained by CPs and PPMVs in Kaduna and Lagos states, Nigeria on the IntegratE project. Data collection was conducted between August and September 2019, and between May 2022 and June 2023. Quantitative telephone interviews were conducted with eligible clients within six (6) weeks of obtaining DMPA-SC commodities for self-injection from a trained CP or PPMV.
The purpose of this study was to examine the factors associated with the acceptance of DMPA-SC self-injection training when provided by trained CPs and PPMVs (known as drug shops) in Lagos and Kaduna states.
Recommended Citation
Akomolafe, Toyin O., Emeka E. Okafor, Sikiru Baruwa, Osimhen I. Ubuane, Michael Alagbile, Delafreda Ukaga, Ijeoma Nwankwo, and Rodio Diallo. 2024. "Factors associated with the acceptability of self-injection training by clients receiving DMPA-SC services from community pharmacies and Patent and Proprietary medicine Vendors in Nigeria," https://doi.org/10.7910/DVN/QI0VBT, Harvard Dataverse.
DOI
10.7910/DVN/QI0VBT
Language
English
Project
The IntegratE Project